C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/1999
10/28/1999	WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999	WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999	WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999	WO1999054446A2 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
10/28/1999	WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999	WO1999054359A1 Matrix binding factor
10/28/1999	WO1999054357A1 Novel cytokine-like protein
10/28/1999	WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999	WO1999054350A1 Novel omega conotoxin peptides
10/28/1999	WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999	WO1999054342A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
10/28/1999	WO1999053954A1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
10/28/1999	WO1999053944A1 Method for treating the endotoxic shock in mammals
10/28/1999	WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999	WO1999053757A1 Autoantigenic fragments, methods and assays
10/28/1999	WO1999042839A3 Treating cancer
10/28/1999	WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999	WO1999041379A9 Members of the d52 gene family
10/28/1999	WO1999041378A9 Members of the d52 gene family
10/28/1999	WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
10/28/1999	WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999	WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999	DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999	DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999	DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
10/28/1999	CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999	CA2329495A1 Autoantigenic fragments, methods and assays
10/28/1999	CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999	CA2328463A1 Matrix binding factor
10/28/1999	CA2326623A1 Gene encoding syntaxin interacting protein
10/28/1999	CA2326067A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
10/28/1999	CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999	CA2325822A1 Soluble protein ztmpo-1
10/28/1999	CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999	CA2324297A1 Sh2 domain-containing peptides
10/28/1999	CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/28/1999	CA2294980A1 Method for the treatment of endotoxic shock in mammels
10/28/1999	CA2269103A1 Peptides binding to bone marrow stromal cell antigen
10/27/1999	EP0951563A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
10/27/1999	EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999	EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
10/27/1999	EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999	EP0951549A1 Mammalian chemokines
10/27/1999	EP0951543A1 Human glycine transporter
10/27/1999	EP0951542A2 Secreted proteins and polynucleotides encoding them
10/27/1999	EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999	EP0951469A1 Novel compounds
10/27/1999	EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999	EP0769144B1 Assay for inhibitors of dp-1 and other dp proteins
10/27/1999	EP0533862B1 Recombinant human factor viii derivatives
10/27/1999	EP0167575B2 Cardiodilatine, a peptide hormone and production process thereof
10/27/1999	CN1233288A GnRH-leukotoxin chimeras
10/27/1999	CN1233279A Detergent compositions comprising antibody controlled lipolytic activity
10/27/1999	CN1232876A Expression of human hemoglobin alpha and beta genes in colibacillus
10/26/1999	US5973134 Rat CNP complementary DNA and precursor protein
10/26/1999	US5973133 Mutant S182 genes
10/26/1999	US5973132 Expression of dna coding for house dust mite allergens.
10/26/1999	US5973123 Monoclonal antibody, or fragment thereof, which has an affinity for native melanoma inhibitory activity protein
10/26/1999	US5973119 Cyclin E genes and proteins
10/26/1999	US5973118 A polypeptide which codes a trypsin inhibitor; for purification of tissue plasminogen activators
10/26/1999	US5973117 Isolated and purified receptor protein endogenous to rt, bovine, or human, capable of binding a pituitary adneylate cyclase activating polypeptide (pacap) or salt, and amino acid sequences encoding it; diagnostic, e.g. of neuropathy
10/26/1999	US5973116 Compounds for targeting
10/26/1999	US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999	US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999	US5972886 Amino acid sequences, a gene coding for stimulating cell differentiation of megakaryocytes; increasing blood platelet cells
10/26/1999	US5972708 Plasmid stabilization
10/26/1999	US5972698 Tryptase is expressed virtually exclusively by mast cells.
10/26/1999	US5972687 Toxin gene from Xenorhabdus nematophilus
10/26/1999	US5972676 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/26/1999	US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade.
10/26/1999	US5972659 Introducing into e. coli a heterologous plasmid expression vector coding for the tobacco mosaic virus protein coat and a pathogen's epitope, separating fusion protein and lowering ph to form a self-aggregated protein and hapten for vaccines
10/26/1999	US5972654 The use of these sequences in the diagnosis, treatment, and prevention of developmental, reproductive, muscle, immunological, and neoplastic disorders.
10/26/1999	US5972652 Polynucleotides encoding secreted proteins
10/26/1999	US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999	US5972650 Can be used as vehicles for the delivery of nucleic acids that can serve as therapeutic agents and as part of vaccines designed to immunize people or animals against viral diseases.
10/26/1999	US5972649 Polynucleotide sequence encoding human multiple endocrine neoplasia type 1 protein
10/26/1999	US5972646 Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
10/26/1999	US5972645 Flea serine protease nucleic acid molecules
10/26/1999	US5972633 Antibodies against heart muscle actin
10/26/1999	US5972609 Utrophin gene promotor
10/26/1999	US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999	US5972597 Methods using modified vaccinia virus
10/26/1999	US5972352 Cloning of mite allergens
10/26/1999	US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999	US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999	US5972335 Compositions for promoting the healing of wounds or fibrotic disorders comprising at least one agent specific to either a growth factor or a protein associated therewith; antibodies
10/26/1999	US5972334 Vaccines for treatment of lymphoma and leukemia
10/26/1999	CA2057536C Cloning and expression of borrelia lipoproteins
10/26/1999	CA1340805C Nucleotide sequence incoding plant ribosome inactivating protein
10/21/1999	WO1999053310A1 Antigen
10/21/1999	WO1999053080A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells
10/21/1999	WO1999053078A2 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999	WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999	WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999	WO1999053066A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999	WO1999053061A2 Tumor associated nucleic acids and uses therefor
10/21/1999	WO1999053060A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999	WO1999053059A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
10/21/1999	WO1999053058A1 Vertebrate patched-2 protein
10/21/1999	WO1999053054A1 Axor4 g-protein-coupled receptor

1 ... 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 ... 1125